Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,432 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A new ATL xenograft model and evaluation of pyrrolidine dithiocarbamate as a potential ATL therapeutic agent.
Nakamura D, Yoshimitsu M, Kuroki A, Hachiman M, Kamada Y, Ezinne CC, Arai A, Inoue H, Hamada H, Hayashida M, Suzuki S, Fujino S, Arima N, Arima M, Tabuchi T, Okada S, Arima N. Nakamura D, et al. Among authors: inoue h. Exp Hematol. 2015 Nov;43(11):944-50. doi: 10.1016/j.exphem.2015.06.303. Epub 2015 Jul 11. Exp Hematol. 2015. PMID: 26169955 Free article.
A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
Kawada H, Yoshimitsu M, Nakamura D, Arai A, Hayashida M, Kamada Y, Maekawa K, Fujino S, Arima M, Arima N, Tabuchi T, Inoue H, Hamda H, Suzuki S, Matsushita K, Arima N. Kawada H, et al. Among authors: inoue h. Biol Blood Marrow Transplant. 2015 Apr;21(4):696-700. doi: 10.1016/j.bbmt.2014.12.020. Epub 2014 Dec 24. Biol Blood Marrow Transplant. 2015. PMID: 25542158 Free article. Clinical Trial.
Case of a patient with progressive adult T-cell leukemia/lymphoma treated successfully by reduced-intensity conditioning stem cell transplantation from an HLA-incompatible related donor.
Fujiwara H, Kawada H, Matsushita K, Hamada H, Ozaki A, Inoue H, Yoshimitsu M, Kukita T, Arimura K, Ohtsubo H, Uozumi K, Arima N, Tei C. Fujiwara H, et al. Among authors: inoue h. Int J Hematol. 2005 Nov;82(4):357-61. doi: 10.1532/IJH97.05047. Int J Hematol. 2005. PMID: 16298831
Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T-cell leukaemia-lymphoma.
Tokunaga M, Yonekura K, Nakamura D, Haraguchi K, Tabuchi T, Fujino S, Hayashida M, Maekawa K, Arai A, Nakano N, Kamada Y, Kubota A, Inoue H, Owatari S, Takeuchi S, Takatsuka Y, Otsuka M, Hanada S, Matsumoto T, Yoshimitsu M, Ishitsuka K, Utsunomiya A. Tokunaga M, et al. Among authors: inoue h. Br J Haematol. 2018 May;181(4):539-542. doi: 10.1111/bjh.14634. Epub 2017 Apr 3. Br J Haematol. 2018. PMID: 28369823 Free article. No abstract available.
6,432 results